Working... Menu

The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach (TAPIR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01933724
Recruitment Status : Recruiting
First Posted : September 2, 2013
Last Update Posted : October 11, 2018
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Office of Rare Diseases (ORD)
National Center for Advancing Translational Science (NCATS)
Rare Diseases Clinical Research Network
Information provided by (Responsible Party):
University of South Florida